Indian Government Further Lowers the Stent Prices in 2nd Revision

Indian govt further lowers the Stent prices in 2nd revision
The National Pharmaceutical Pricing Authority (NPPA) on Monday announced new stent prices, capping trade margin at 8% and requiring the price of catheters, etc. to be mentioned separately during billing. This will ensure transparency in billing and further help the patients.
According to NPPA notification, the Patients will have an option to get a stent and accessories from outside the establishment. The new costs that NPPA notified Stent cost rs 27890 and bare metal stent rs 7660 will be applicable till 31st March 2019 and will attract GST. Those selling lower than the ceiling rates cannot increase the price.

The price of accessories like catheters and balloons will need to be displayed separately in the bill along with their brand names. The government has also invited comments to check the cost of the guide wire, balloon catheters and guiding catheters which are being sold at 15- to 400% margins.

Companies who want to discontinue their stent will have to give a six months-notice.

Bare metal stents (BMS) have a significantly higher rate of restenosis and the need for target vessel revascularization compared with all drug-eluting stents (DES).For most patients undergoing percutaneous coronary intervention (PCI) with stenting, one recommends current-generation DES rather than BMS. Circumstances in which implantation of a BMS is considered Patients in whom a DES cannot be implanted due to large vessel size (>5 mm). Patients for whom it is known at the time of PCI that dual antiplatelet therapy (DAPT) cannot be used for more than four to six weeks. This includes patients who require noncardiac surgery within six weeks of PCI and (patients) with active bleeding at the time of PCI.

Be the first to comment